GenFleet Therapeutics (Shanghai) Inc.
Status: Publicly traded
Direct answer
GenFleet Therapeutics (Shanghai) Inc. is publicly traded on HKSE under the ticker 2595.HK.
GenFleet Therapeutics (Shanghai) Inc., a biopharmaceutical company, develops treatment options in the fields of oncology, autoimmune, and inflammatory diseases in the United States. The company develops GFH375, an orally bioavailable small molecule inhibitor of Kirsten rat sarcoma (KRAS) G12C in a Phase III trial for the treatment of pancreatic cancer, as well as in Phase II trials for the treatment of non-small...
Can you invest in GenFleet Therapeutics (Shanghai) Inc.?
Yes. GenFleet Therapeutics (Shanghai) Inc. is publicly traded on HKSE under the ticker 2595.HK.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for GenFleet Therapeutics (Shanghai) Inc.
Detailed equity research is provided by MarketSnap.